Do you want to read an article? Please log in or register.
Major adverse events and atrial tachycardia in Ebstein's anomaly predicted by cardiovascular magnetic resonance
Cardiac Arrest or DeathHeart FailureThrombosis and Stroke
Related content
Cardiovascular Risk and Diseases
Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial
JAMA Cardiol.
Verma S, Bain SC, Buse JB, Idorn T, Rasmussen S, Ørsted DD, Nauck MA
doi: 10.1001/jamacardio.2019.3080.
Cardiovascular Risk and DiseasesHeart Failure
Right Ventricular Ejection Fraction for the Prediction of Major Adverse Cardiovascular and Heart Failure-Related Events: A Cardiac MRI Based Study of 7131 Patients With Known or Suspected Cardiovascular Disease
Circ Cardiovasc Imaging
Purmah Y, Lei LY, Dykstra S, Mikami Y, Cornhill A, Satriano A, Flewitt J, Rivest S, Sandonato R, Seib M, Lydell CP, Howarth AG, Heydari B, Merchant N, Bristow M, Fine N, Gaztanaga J, White JA
doi: 10.1161/CIRCIMAGING.120.011337
Cardiovascular Risk and Diseases
Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies
J Am Heart Assoc.
Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L
doi: 10.1161/JAHA.116.004947.
Cardiovascular Risk and Diseases
Prognostic Value of the CHADS2 Score for Adverse Cardiovascular Events in Coronary Artery Disease Patients Without Atrial Fibrillation-A Multi-Center Observational Cohort Study
J Am Heart Assoc.
Tabata N, Yamamoto E, Hokimoto S, Yamashita T, Sueta D, Takashio S, Arima Y, Izumiya Y, Kojima S, Kaikita K, Matsui K, Fujimoto K, Sakamoto K, Shimomura H, Tsunoda R, Hirose T, Nakamura N, Sakaino N, Nakamura S, Yamamoto N, Matsumura T, Kajiwara I, Koide S, Sakamoto T, Nakao K, Oshima S, Tsujita K; Kumamoto Intervention Conference Study (KICS) Investigators
doi: 10.1161/JAHA.117.006355.
Cardiovascular Risk and Diseases
Development and validation of a multivariable prediction model for major adverse cardiovascular events after early stage breast cancer: a population-based cohort study
Eur Heart J.
Abdel-Qadir H, Thavendiranathan P, Austin PC, Lee DS, Amir E, Tu JV, Fung K, Anderson GM
doi: 10.1093/eurheartj/ehz460.
Atrial Fibrillation
Major Adverse Cardiovascular Events Associated with Post-Operative Atrial Fibrillation after Non-Cardiac Surgery: A Systematic Review and Meta-analysis
Circ Arrhythm Electrophysiol.
AlTurki A, Marafi M, Proietti R, Cardinale D, Blackwell R, Dorian P, Bessissow A, Vieira L, Greiss I, Essebag V, Healey JS, Huynh T
doi: 10.1161/CIRCEP.119.007437.
COMMENTED
Atrial Fibrillation
Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
Am Heart J.
Dalgaard F, North R, Pieper K, Fonarow GC, Kowey PR, Gersh BJ, Mahaffey KW, Pokorney S, Steinberg BA, Naccarrelli G, Allen LA, Reiffel JA, Ezekowitz M, Singer DE, Chan PS, Peterson ED, Piccini JP
doi: 10.1016/j.ahj.2020.01.001.
Cardiovascular Risk and Diseases
Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes: A Randomized Clinical Trial
JAMA.
Ray KK, Nicholls SJ, Buhr KA, Ginsberg HN, Johansson JO, Kalantar-Zadeh K, Kulikowski E, Toth PP, Wong N, Sweeney M, Schwartz GG, BETonMACE Investigators and Committees.
doi: 10.1001/jama.2020.3308.
Atrial Fibrillation
Atrial Fibrosis by Late Gadolinium Enhancement Magnetic Resonance Imaging and Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up Data
doi: 10.1161/JAHA.117.006313.